Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate–activated protein kinase and phosphatidylinositol-3 kinase pathways-Reference-Cited by-同舟云学术

Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate–activated protein kinase and phosphatidylinositol-3 kinase pathways

Published:2011-01 Issue:1 Volume:60 Page:43-51
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Yuan Hai-Dan,Kim Sung Jip,Chung Sung-Hyun

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Global and societal implications of the diabetes epidemic;Zimmet;Nature,2001

2. Decreased beta-cell mass in diabetes; significance, mechanisms and therapeutic implications;Donath;Diabetologia,2004

3. Oral antidiabetic agents: current role in type 2 diabetes mellitus;Krentz;Drugs,2005

4. Ginseng compounds: an update on their molecular mechanisms and medical applications;Lu;Curr Vasc Pharmacol,2009

5. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells;Wakabayashi;Biochem Biophys Res Commun,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Studies on the Pharmacological Activities and Structural Modifications of Compound-K;Mini-Reviews in Medicinal Chemistry;2022-12

2. SYNERGISTIC EFFECT OF EXTRACTS OF GINKGO BILOBA LEAF AND PANAX GINSENG ROOT ON CARBOHYDRATE AND LIPID METABOLISM GENE EXPRESSION IN ALLOXAN INDUCED DIABETIC RATS;The Journal of Animal and Plant Sciences;2020-08-03

3. Ginseng metabolite Protopanaxadiol induces Sestrin2 expression and AMPK activation through GCN2 and PERK;Cell Death & Disease;2019-04

4. Ginseng for the treatment of diabetes and diabetes-related cardiovascular complications: a discussion of the evidence;Canadian Journal of Physiology and Pharmacology;2019-04

5. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice;International Immunopharmacology;2018-10